Table 2.
Parameter | Data |
---|---|
Demographic parameter | |
Sex | f |
Age y | 56 |
Age of onset y | 54 |
Psychopathology | |
Orientation dysfunction | 1 |
Attentional dysfunction | 1 |
Memory disturbances | 1 |
Formal thought disorder | 1 |
Affective disturbance | 1 |
Drive and psychomotor disturbance | 1 |
CSF | |
Cell count (<5 µL) | 0 |
Albumin mg/L | 261 |
NSE (<30 ng/mL) | 24.1 |
S100 (<2.7 µg/L) | 1.6 |
Tau protein (<450 pg/mL) | 128 |
P tau protein 181 (<61 pg/mL) | 70 |
Aß42 (>450 pg/mL) | 1539 |
Aß40 | 19,275 |
Ratio Aß42/40 × 10 (>0.5) | 0.8 |
Blood–brain barrier disturbance | Not present |
Intrathecal IgG synthesis | Not present |
Serum | |
NSE (<30 ng/mL) | 22.8 |
S100 (<1.5 µg/L) | 0.06 |
MRI | |
Generalized atrophy | 0 * |
Focal atrophy | 1 # |
Hippocampal atrophy | 0 |
Vascular pathology | 0 |
Abbreviations: Aß42 = amyloid-ß 42, Aß40 = amyloid-ß 40, CSF = cerebrospinal fluid, MRI = magnetic resonance imaging, p-tau protein 181 = phosphorylated tau protein 181, ratio Aß42/40 = ratio of amyloid-ß 42/ratio of amyloid-ß 40, y = years. The values are depicted as mean ± standard deviation. For laboratory data normal ranges are shown in brackets. Reference values: refers to reference values from the Neurochemistry Laboratory, Neurology Department, University Medical Center Göttingen. * 0 = item not present, # 1 = item present.